Home » Topics » BioWorld Science

BioWorld Science
RSS

RPR continues research into taxanes

Dec. 5, 1996

New nonoxynol-9 formulations tested at University of Kentucky

Dec. 4, 1996

Techniclone explores MAb-based drug delivery technologies

Dec. 4, 1996

Assay for diagnosing and monitoring kidney disease available for licensing

Dec. 4, 1996

Method of imaging nicotinic acetylcholine receptors offered for licensing

Dec. 4, 1996

NIH offers invention for treating and diagnosing HIV infection for licensing

Dec. 4, 1996

Another Barr generic drug cleared by the FDA

Dec. 4, 1996

NIH offers licenses for invention related to fusin

Dec. 4, 1996

New therapeutic approach to neurogenerative disorders

Dec. 4, 1996

Neurochem/Parke-Davis collaboration on antiamyloid compounds

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...